Introduction {#S0001}
============

*Mycoplasma gallisepticum* (*MG*) is widely distributed throughout the world and causes huge economic losses to the poultry industry.[@CIT0001] *MG* is considered as the most economically important pathogen of the four pathogenic *Mycoplasma* species due to its economic losses.[@CIT0002] Current methods of controlling *MG* infections among avian species, include bio-surveillance practices, vaccines, and medication.[@CIT0003]

*Mycoplasma* treatment has also been restricted due to antibiotic resistance, drug residues, and side effects.[@CIT0004] While, the active ingredients of traditional Chinese medicine have been proven to have a variety of biological effects, which not only significantly inhibit the pathogenic microorganisms but also improve the body's immunity.[@CIT0005] The effect of traditional Chinese medicine on *MG* has made extensive progress in pharmacodynamics, but the relevant mechanism is still unclear.[@CIT0006] Baicalin is one of the most common monomers of these traditional Chinese medicine.[@CIT0007] Previous reports demonstrated that baicalin possess potential anti-inflammatory properties.[@CIT0008],[@CIT0009] Therefore, baicalin is the major active constituent isolated from the root of *Scutellaria baicalensis*[@CIT0010] and was used as an anti-inflammatory agent against *MG* infection in this study.

Ying et al provide evidence[@CIT0011] that *MG* lipid-associated membrane proteins (LAMPs) activate IL-1β production through the NF-κB pathway via TLR2 and MyD88. Tian Wei found both TLR2-2 and TLR6 were upregulated upon *MG* infection, followed by upregulation of the downstream NF-κB-mediated inflammatory responses.[@CIT0012] Guo et al demonstrated the anti-inflammatory effects of baicalin in a mouse model against *Staphylococcus aureus*-induced mastitis.[@CIT0013] The results showed that baicalin reduced the expression of the proinflammatory cytokines IL-1β, TNF-α, and IL-6 by inhibiting NF-κB and p38 phosphorylation. However, it is unknown whether baicalin can play a similar role in *MG* infection. Thus, this study was conducted to determine the effects of baicalin against inflammatory responses in chicken and in DF-1 cells infected with *MG* and to better understand the underlying mechanism of action of baicalin.

Materials and Methods {#S0002}
=====================

Ethics Approval Statement {#S0002-S2001}
-------------------------

The present study was conducted under the approval of Institutional Animal Care and Use Committee of Northeast Agricultural University (Heilongjiang province, China) (SYXK (Hei) 2012--2067) in accordance with Laboratory animal-Guideline for ethical review of animal welfare (GB/T 35892--2018, National Standards of the People's Republic of China).

Mycoplasma Strains, Drug, and Chickens {#S0002-S2002}
--------------------------------------

The *MG* strain R~low~ was obtained from Harbin Institute of Veterinary Medicine, Chinese Academy of Agricultural Science. The mycoplasma were cultured at 37°C in modified Hayflicks medium supplemented with 20% FBS (Gibco BRL), 10% freshly prepared yeast extract, 0.05% Penicillin, 0.05% thallium acetate, and 0.1% Nicotinamide adenine dinucleotide (NAD).[@CIT0014] *MG*, in its mid-exponential phase indicated by the color change of phenol red dye from red to orange, which was used to challenge chickens at a density of 1×10^9^ CCU/mL (color change unit per milliliter) in the culture medium.[@CIT0015] Baicalin powder (purity 98.0%) was kindly supplied by the Huifeng Animal Health Co., Ltd. (LOT: RH128699, Heilongjiang, China). Eighty one-day-old commercial Leghorn chickens were obtained from Chia Chau Chicken Farm (Harbin, Heilongjiang, China). The chickens were in healthy conditions, *MG* and *Mycoplasma synoviae*-free, and did not undergo vaccination. They were fed with antibacterial-free balanced ad libitum feed and provided free access to ultra-pure water. They were raised to 1 week under controlled conditions at 25°C.

Cell Culture {#S0002-S2003}
------------

Chicken fibroblast cell lines (DF-1 cells) were obtained from Harbin Institute of Veterinary Medicine, Chinese Academy of Agricultural Science. The cells were cultured in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 IU/mL penicillin--100 μg/mL streptomycin at 37°C under a humidified air with 5% CO~2~. DF-1 cells were seeded in 6-well plates at a concentration of 1×10^7^ cells/well and cultured in an incubator at 37 °C with 5% CO~2~ for at least 12 hrs prior to exposure to *MG*. The cell vitality was assessed by MTT assay as described previously.[@CIT0016] Significant cell death was observed at a dose greater than 500 MOI (MOI =0:10^7^--5 × 10^9^:10^7^, mycoplasma: cell).[@CIT0017] The cells were divided into six experimental groups and treated with baicalin at the following concentrations: 0, 5, 10, 20, 40, and 60 μg/mL. The cell viability were assessed by MTT assay. To choose the dose of baicalin, DF-1 cells in 12-well plates were infected with *MG* (MOI = 500). The cells were treated with baicalin (15 μg/mL) for 0, 6, 12, 24, and 48 hrs, respectively. The cell vitality was assessed by MTT assay.

Experimental Grouping {#S0002-S2004}
---------------------

DF-1 cells were divided into 5 groups including control group (control), *MG* infection group (*MG), MG* + baicalin low-dose group (low), *MG* + baicalin medium-dose group (medium), and *MG* + baicalin high-dose group (high). The final concentrations of baicalin used for subsequent experiments are 5, 10, and 15 μg/mL. Cells were cultured at 37°C for 24 hrs, and the cell supernatant was collected. The levels of TNF-α and IL-1β were detected by enzyme-linked immunosorbent assay (ELISA) kits.

MG Infection Model and Experimental Protocols {#S0002-S2005}
---------------------------------------------

After pre-experiments, the model was determined according to the development of *MG* infection course. Briefly, we injected 7-day-old chickens with 0.2 mL of rejuvenated *MG* R~low~ at a concentration of approximately 1×10^9^ color change units per milliliter (CCU/mL) in logarithmic phase into the bilateral air sacs of the thoracic region. The infection model established in this way have clinical symptoms on the fifth day and reach the peak of infection on the seventh day post-infection. Eighty chickens were divided randomly into 4 groups as follows:

\(1\) Control group (CG): Chickens in the CG were fed only with basal diet and were direct air sac inoculation with the culture medium 0.2 mL on day 7.

\(2\) *MG*-infected control group (*MG*G): The *MG* infection model was constructed one time by direct air sac inoculation with 1×10^9^ CCU/mL *MG* R strain 0.2 mL on day 7.

\(3\) *MG* infection + baicalin administration group (*MG* + BG): The same infection model as *MG*G, then treated with baicalin mixed water, given orally by gavage. The treatment started on day 10 and continued for a week, once in a day at a dose of 450 mg/kg.[@CIT0018]

\(4\) Baicalin control group (BG): The same dose of baicalin (450 mg/kg) was given orally to chickens by gavage started at day 10 and continued for a week.

Each group provided randomly with 20 chickens and housed in 4 positive pressure fiberglass isolators. The measurement was determined according to the preliminary pre-test results of the laboratory. In our preliminary experiments ([[Supplementary material 1](http://www.dovepress.com/get_supplementary_file.php?f=231908.xlsx)]{.ul}), the results obtained from the single dose of 450 mg/kg is similar to the recommended dose of tylosin tartrate (Jilin Yigefeng Animal Pharmaceutical Co., Ltd.).

On days 11, 14, and 17 (1, 4, and 7 days post treatment), 6 chickens from each group were sacrificed by cardiac puncture method following euthanasia with sodium pentobarbital as described previously.[@CIT0019]

Gross and Histopathological Examination of Lesions {#S0002-S2006}
--------------------------------------------------

The severity of the gross air sac lesions was scored on a scale of 0--3, using a modification of a system as described previously.[@CIT0020] One centimeter of trachea proximal to the middle part was stored in buffered 10% formalin for histology. The tracheal mucosal thickness was measured in the middle trachea at four different points transected by a vertical and a horizontal line to determine the mean mucosal thickness at each level. The tracheal lesion score was determined from the same three discontinuities of the trachea. The tracheal infection score was also calculated on the basis of 0 to 3 scoring system published by Kirkpatrick, Mahmoudian.[@CIT0021] All scoring systems and the tracheal mucosal thickness were determined by a pathologist unaware of the experimental conditions.

Transmission Electron Microscopy {#S0002-S2007}
--------------------------------

Transmission electron microscopy was performed as described in a previous study (Zhang et al, 2015). Briefly, lung tissue and the middle part of the trachea were trimmed into small pieces of 1 mm^3^ and fixed overnight in 2.5% glutaraldehyde. They were washed with PBS twice and post-fixed in 1% osmium tetroxide at 4°C for 1 hr. Next, the tissues were dehydrated by ethanol series and 100% acetone, embedded in epoxy resins. The ultrathin sections were stained with uranyl acetate and lead citrate and then observed under a GEM-1200ES transmission electron microscope (JEOL Ltd., Tokyo, Japan).

Serology {#S0002-S2008}
--------

Blood samples were collected from all chickens on day 11, 14, and 17 (1, 4, and 7 days post treatment) of the trial. Serum antibody against *MG* in each bird was assessed by serum plate agglutination (SPA) assay using freshly collected sera and stained *MG* agglutination antigen purchased from the China Institute of Veterinary Drug Control (Beijing, China). Results were scored on a scale of 0--4 according to the size of clumps and the clarity of the background. Meanwhile, the serum was assayed for TNF-α and IL-1β levels by using ELISA kits in accordance with the manufacturer's instructions (Shanghai Enzyme-linked Biotechnology Co., Ltd.).

Real-Time PCR {#S0002-S2009}
-------------

Real-Time PCR (RT-PCR) was performed to analyze gene expression using a Biosystem 7500 Real-Time PCR System thermocycler (Roche) and Taq SYBR Green qPCR Premix (Beijing Tianxiruizhi Science and Technology Co., Ltd.). Total RNA was extracted using TRI reagent, and 1 μg of RNA was reverse transcribed with All-in-one First-Stand Synthesis MasterMix. Oligo nucleotide primers ([Table 1](#T0001){ref-type="table"}) for GAPDH, IL-1β and TNF-α were designed by Sangon Biotech (Shanghai, China), based on the sequences available in NCBI database. Each sample was analyzed in triplicate. The fold change in gene expression was calculated using the △△cycle time (Ct) method after the expression level was normalized with GAPDH gene taken as internal standard.Table 1Sequences of the Oligo Nucleotide Primers Used for RT-PCRPrimers NamePrimers SequencesFragment LengthAccession NumberIL-1β (U)GCATCAAGGGCTACAAGCTC131 bpNM_204524IL-1β (L)CAGGCGGTAGAAGATGAAGCTNFα (U)CAGATGGGAAGGGAATGAAC101 bpJN942589.1TNFα (L)AGAACAGCACTACGGGTTGCGAPDH (U)GAACATCATCCCAGCGTCCA82 bpNM_204305GAPDH (L)CGGCAGGTCAGGTCAACAAC

Western Blot {#S0002-S2010}
------------

The cells were washed twice with cold PBS and 100 mg lung tissues, then total proteins were prepared in radio-immunoprecipitation assay (RIPA) lysis buffer containing 0.5 mM PMSF, respectively. The mixture was homogenized for 2 mins at a low frequency of 65 Hz using an automatic sample rapid grinding machine (Shanghai Jingxin Industrial Development Co., Ltd.), followed by high speed centrifugation (12,000 × g for 30 mins) at 4°C. Then, the supernatant protein content was determined by using BCA protein assay kit. Equivalent amounts of protein were separated in a 10--15% gel by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) run on 120 v for 1 hr, and then transferred onto nitrocellulose (NC) membranes run on 120 v for 90 mins.[@CIT0022] After blocking in 5% non-fat dried milk-TBST (25 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20; pH 7.4) at room temperature for 1 hr, the membranes were incubated overnight on a shaker at 4°C with primary antibodies against: GAPDH (1:200 dilution, Boster Biological Technology Co. Ltd); TLR2 (1:300 dilution, Absin Bioscience Inc. Shanghai, China); p65 (1:1000 dilution); P-p65 (1:1000 dilution); P-IκB (1:1000 dilution); IκB (1:1000 dilution); and MyD88 (1:1000 dilution, Bioss Bioscience Inc. Beijing, China). Secondary anti-mouse or anti-rabbit IgG peroxidase was used for 1 hr, and then bound immune-complexes were detected using enhanced chemiluminescence (ECL) detection.

Statistical Analysis {#S0002-S2011}
--------------------

Data are presented as mean results ± standard deviation (SD). The significance was determined using one-way ANOVA followed by LSD and Dunnett's T3 test. The data were analyzed using the GraphPad Prism (version 5.01). Values (p ≤ 0.05) were considered as statistically significant.

Results {#S0003}
=======

Histopathological Changes and SPA Score {#S0003-S2001}
---------------------------------------

The histopathological changes in the air sacs of each group were examined. No pathological changes were observed in CG and BG ([Figure 1A](#F0001){ref-type="fig"} and [D](#F0001){ref-type="fig"}). In *MG*G, the air sacs showed cloudy thickening and more than several yellowish foci, and there were only cloudy appearance and several yellowish foci in *MG* + BG ([Figure 1B](#F0001){ref-type="fig"} and [C](#F0001){ref-type="fig"}). Tracheal tissues were harvested at 1, 4, and at 7 days after baicalin treatment. Tracheal sections were subjected to hematoxylin and eosin staining. The *MG*G showed the tracheal mucosal thickening, cilia stick together, or even fall off residual loss, epithelial cell proliferation, and a large number of lymphocytes infiltrated in the submucosa ([Figure 2A](#F0002){ref-type="fig"} and [B](#F0002){ref-type="fig"}). While, the lesion in *MG* + BG reduced significantly, there were slight thickening of the mucosa due to diffuse lymphocytic infiltration ([Figure 2A](#F0002){ref-type="fig"} and [C](#F0002){ref-type="fig"}). No changes were observed in CG and BG ([Figure 2A](#F0002){ref-type="fig"} and [D](#F0002){ref-type="fig"}). From the results of SPA score, it can be seen that *MG*G and *MG* + BG showed statistical differences after 7 days post-treatment. The SPA score of *MG* + BG reduced significantly, indicating that baicalin has certain therapeutic effects. Gross air sac lesions were similar to SPA scores and showed significant differences 7 days after treatment. The score of the *MG* + BG decreased after 7 days of administration, indicating that the therapeutic effect was achieved ([Figure 3A](#F0003){ref-type="fig"}).Figure 1Anatomical observation of air sac lesions. (**A**) CG = untreated control group. (**B**) *MG*G = *MG*-infected control group. (**C**) *MG* + BG= *MG* infection + baicalin administration group. (**D**) BG = baicalin control group. The following is the same.**Note:** →means cloudy appearance and several yellowish foci in air sac.Figure 2(**A**). Histopathology of tracheal tissue after treatment with baicalin (100 ×). Experimental groups including (a) CG (b) *MG*G (c) *MG* + BG, and (d) BG. The tracheal mucosa of (a) and (d) with a lesion score of 0 (section from CG and BG), with the trachea lined with pseudo-stratified column are epithelium with an intact brush border. The red arrow of (b) and (c) indicates a significant thickening of the tracheal mucosa thickness. Circles represent cilia fused together, or even fallen off residual loss. The box section indicates that a large number of inflammatory cells infiltrate the submucosa. (**B**). Ultrastructural observation of lung (15,000 ×). Experimental groups are represented as (a) CG, (b) *MG*G, (c) *MG* + BG, and (d) BG. The red box section shows that the alveolar type I epithelial cells was broken and cytoplasmic fragmentation. The circle indicates that the alveolar type II epithelial cells were damaged and the cytoplasmic vacuoles were formed. (**C**). Ultrastructural observation of trachea (8000 ×). Experimental groups consist of (a) CG, (b) *MG*G, (c) *MG* + BG, and (d) BG. The red box section shows ruptured cilia, inverted, cytoplasmic swelling, decreased matrix electron density, and formation of umbrella-like protrusions outside the cell. The circle indicates that partial ciliated cells are necrotic and some cilia shedding.Figure 3(**A**). Mean score in baicalin treatment trial. The values with star differ significantly (with \*0.01 \< P \< 0.05) or very significantly (with \*\*P \< 0.01) compared to the CG. The values with hash differ significantly (with ^\#^0.01 \< P \< 0.05) or marked significant (with ^\#\#^P \< 0.01) compared to the *MG*. Values are presented as the means ± SD (n = 6). The following is the same. (a) Mean serum plate agglutination (SPA) score. (b) Mean air sac lesion score. (c) Mean tracheal lesion score. (**B**). The expression levels of cytokine concentrations by ELISA in the serum. (**C**). Effect of baicalin on the expression of the mRNA relative expression cytokine concentrations by RT-PCR in the lung tissues.

Ultrastructural Observation of Lungs and Trachea {#S0003-S2002}
------------------------------------------------

In order to observe the effect of baicalin on *MG* infection from the ultrastructural level of cells, the lung and tracheal tissues were selected from each group for transmission electron microscopy 7 days after the treatment of baicalin mixed water. In the trachea, we can observe that the ciliated cells of the *MG*G have ruptured cilia, inverted, cytoplasmic swelling, decreased matrix electron density, and formation of umbrella-like protrusions outside the cell; partial ciliated cells are necrotic; mitochondria, rough endoplasmic reticulum expansion, even complete vacuolization; goblet cell reactive hypertrophy. Baicalin partially ameliorated the abnormal pathological changes in the chickens trachea infected with *MG* compared to *MG*G ([Figure 2C](#F0002){ref-type="fig"}). In the transmission electron microscopic observation of lung tissue, we found that the cytoplasm of the alveolar type I epithelial cells in *MG*G was broken and the basement membrane was exposed. In addition, the alveolar type II epithelial cells were damaged and the cytoplasmic vacuoles were formed. While, the degree of lesions in *MG* + BG was significantly reduced ([Figure 2B](#F0002){ref-type="fig"}).

Effect of Baicalin on Inflammatory Cytokines in Lung Tissues and Cells After Treatment {#S0003-S2003}
--------------------------------------------------------------------------------------

In order to determine the effects of baicalin and/or *MG* infection on inflammatory markers such as TNF-α and IL-1β, we measured the level of TNF-α and IL-1β in serum and cells supernatant. The results showed that compared with CG, an increase in the expression of explosive inflammatory factors (P \< 0.01) has been noted in *MG*G, and the expression of inflammatory factors decreased significantly 7 days post-treatment. Compared with the *MG*G, the expression levels of inflammatory factors IL-1β and TNF-α in the *MG* + BG and the BG were significantly lower (P \< 0.01) ([Figure 3B](#F0003){ref-type="fig"} and [C](#F0003){ref-type="fig"}). After 4 days of treatment (7 days after *MG* infection), the mRNA expression levels of IL-1β and TNF-α were significantly increased in the *MG*G compared with other groups, and the *MG* + BG was significantly different (P \< 0.01). It has been noted that the expression of inflammatory factors in the infected control group was significantly decreased (P \< 0.05) 7 days post-treatment. After DF-1 cells infected with *MG*, the secretion levels of TNF-α and IL-1β were significantly increased (p \< 0.05) compared to control group. While, the levels of TNF-α and IL-1β were significantly (p \< 0.05) decreased with baicalin-treatment in a dose-dependent manner ([Figure 5D](#F0005){ref-type="fig"}).

Baicalin Suppressed TLR2 and P65 Expression in the Lung Tissues {#S0003-S2004}
---------------------------------------------------------------

Baicalin significantly inhibited the rapid increase of TLR2 expression in *MG*G (P \< 0.05). The results showed that baicalin can inhibit the expression of TLR2 and prevent the activation of its downstream signaling pathway in *MG* infection as shown in [Figure 4](#F0004){ref-type="fig"}. In this study, the expression of p65 protein was detected by Western blotting to analyze the activation of NF-κB signaling pathway. The results showed that the phosphorylation level of p65 was significantly increased in the MGG but was significantly reduced in the MG + BG (P \< 0.05) ([Figure 4](#F0004){ref-type="fig"}).Figure 4Western blot assaying on the levels of TLR2, p65, and phosphorylation in the lung tissues. GAPDH was used as a control. The values with star differ significantly (with \*0.01 \< P \< 0.05) or very significantly (with \*\*P \< 0.01) compared to the CG. The values with hash differ significantly (with ^\#^0.01 \< P \< 0.05) or marked significant (with ^\#\#^P \< 0.01) compared to the *MG*. Values are presented as the means ± SD (n = 6).

Effect of Baicalin on Cell Viability {#S0003-S2005}
------------------------------------

After incubation with various concentrations of baicalin (0--60 mg/mL), the viability of cells was determined by MTT method. Baicalin reduced cell viability in a dose- and time-dependent manner ([Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}). Cells exposed to 20 μg/mL of baicalin for 24 hrs exhibited 88.78% cells viability. In order to investigate the effect of baicalin and *MG* on DF-1 cells viability, the relative cell viability was above 80% after treatment with baicalin at the concentrations of 5, 10, and 20 μg/mL, and there was no significant difference among the three concentrations ([Figure 5C](#F0005){ref-type="fig"}). Thus, baicalin at concentrations of 5, 10, and 20 μg/mL were used for subsequent experiments.Figure 5(**A**).  Effect of different concentration of baicalin on cell viability of DF-1 cells. The cells were treated with a series of concentrations (0, 5, 10, 20, 40, and 60 μg/mL) of baicalin for 24 hrs. Data are expressed as the mean ± SD of the three independent experiments. (**B**). Effect of different time of baicalin on cell viability of DF-1 cells. Cells were incubated with 20 μg/mL of baicalin for different time points (0, 6, 12, 24, and 48 hrs). Data are expressed as the mean ± SD of three independent experiments. (**C**). Effect of baicalin and *MG* on cell viability of DF-1 cells.The cell viability of DF-1 cells infection with *MG* (MOI = 500) and treatment with baicalin at concentrations of 5, 10, and 20 μg/mL. (**D**). Cytokines activities assay. The expression levels of cytokine concentrations by ELISA in DF-1 cells after treatment. The values with star differ significantly (with \*0.01 \< P \< 0.05) or very significantly (with \*\*P \< 0.01) compared to the CG (Control group). The values with hash differ significantly (with ^\#^0.01 \< P \< 0.05) or marked significant (with ^\#\#^P \< 0.01) compared to the *MG* (*MG*-infected control group).

Effect of Baicalin on the TLR2-NF-κB Pathway in DF-1 Cells {#S0003-S2006}
----------------------------------------------------------

Compared to the control group, *MG* infection significantly increased the expression of TLR2, MyD88, P-p65, and P-IκB in DF-1 cells (p \< 0.05). The expression of P-p65 and P-IκB in the treatment group was significantly reduced than that in the *MG*-infected group (p \< 0.05) in a concentration-dependent manner. From these results, it has been suggested that baicalin exerts anti-inflammatory effects through the inhibition of NF-κB pathway during *MG* infection ([Figure 6](#F0006){ref-type="fig"}).Figure 6Western blot assaying on the levels of TLR2, MyD88, p65 and phosphorylation, IκB and phosphorylation in DF-1 cells. GAPDH was used as a control gene. The values with star differ significantly (with \*0.01 \< P \< 0.05) compared to the CG (Control group). The values with hash differ significantly (with ^\#^0.01 \< P \< 0.05) compared to the *M*G (*MG*-infected control group).

Discussion {#S0004}
==========

Previous studies established *MG* infection model by various methods, such as nasal drops, intratracheal inoculation, air sac inoculation, mixed infection, immunodeficiency models, and so on.[@CIT0021],[@CIT0023] In order to select a suitable model for drug therapy, our laboratory selected four infection methods for comparative experiments. The method was to construct a model of 7-day-old chicks by air sac inoculation with a concentration of 1×10^9^ CCU/mL (0.2 mL) of *MG* R strain. Therefore, the necropsy samples were taken at 4, 7, and 10 day post infection. In the study of baicalin, researchers found that baicalin can reduce inflammatory cell infiltration[@CIT0024] and inhibit the expression of TLR2 receptor in *Staphylococcus aureus* mastitis.[@CIT0013],[@CIT0025],[@CIT0026] A preliminary study in our lab found that the Chinese medicinal compound "Man Hu Kang" could also alleviate the inflammatory damage caused by *MG* infection, and the active ingredients of the compound were confirmed to be baicalin and chlorogenic acid.[@CIT0027]

The cytokines produce more inflammatory factors through the intercellular transfer and amplification of the alveolar type I epithelial cells, resulting in a waterfall-like burst of inflammation.[@CIT0028] Among them, IL-1β and TNF-α are the main inflammatory factors, and both of them could activate more inflammatory factors by binding to cell membrane surface receptors.[@CIT0029] Compared with the *MG* + BG, it can be clearly observed that the release of inflammatory factors decreased significantly after treatment with baicalin. Our findings indicate that baicalin can reduce the damage caused by excessive secretion of inflammatory factors in chicken and DF-1 cells infected with *MG*. According to the results of pathological clinical manifestations (gross air sac lesion score, tracheal lesion score) and SPA score, it can be found that the tissue damage of the target organ can be reduced and the degree of lesion is significantly reduced after 7 days of treatment with baicalin and found statistical significance.[@CIT0021] *MG* infection caused mitochondrial damage, rough endoplasmic reticulum disruption, and even vacuolization of the trachea. A large myelin-like structure is common in the cytoplasm, and the ciliated cells are condensed, degenerated, shedded, and necrotic. In the lung tissues, the alveolar type I epithelial cells are severely damaged. The alveolar type II epithelial cells proliferate and form vacuoles between the cells. The *MG* + BG mainly showed cilia swelling, mushroom-like edema at the top, cilia fusion, and the damage of alveolar type I epithelial cells was significantly reduced. This finding indicated that baicalin had a protective effect on lung tissues.

In recent years, some breakthroughs have been made in the research on the mechanism of *MG* infection. These advances are important for elucidating the activation of signaling pathways during *MG* infection. *MG*-derived lipid-associated membrane proteins (LAMPs) activate NF-κB through TLR2 in a MyD88-dependent pathway in DF-1 cells.[@CIT0009] Recently, Wu et al (2018) reported the preventive effects of baicalin against atherosclerosis through the suppression of oxidative stress and inflammatory responses via NF-κB and MAPK signaling pathway.[@CIT0030] Daniele found that higher-ordered oligomeric α-synuclein induced a proinflammatory microglial phenotype by directly engaging the heterodimer TLR2 at the cell membrane, leading to the nuclear translocation of NF-κB and the increased production of the proinflammatory cytokines TNF-α (tumor necrosis factor-α) and IL-1β (interleukin-1β) in a MyD88-dependent manner.[@CIT0031] Tian reported that TLR2-2 and TLR6 play important roles in *MG*-induced inflammatory response in chicken embryos.[@CIT0012] Wang et al demonstrated that *M. bovis*-derived LAMPs activate IL-1β production through NF-kB pathway via TLR2 and MyD88.[@CIT0032] In the present study, *MG* induced inflammatory responses through activating TLR2-NF-kB signaling pathway. Our in vitro data showed that *MG* induced inflammatory responses by activating TLR2, MyD88, P-p65 and P-IκB, and baicalin could interfere with the activation of TLR2-NF-kB signaling pathway. Besides NF-κB signaling pathway, further molecular studies are needed to investigate the effect of baicalin on MAPKs, such as JNK and p38 signaling pathway.

NF-κB is a group of important transcription factors involved in many immune processes.[@CIT0033] NF-κB initiates the expression of inflammatory factors in innate immunity.[@CIT0034] In the classical activation pathway of NF-κB, the upstream signal causes activation of the IκK protein kinase complex, promotes phosphorylation of IκB, and then IκB to be degraded by the proteasome. NF-κB is responsible for the phosphorylation of p65 into the nucleus involved in the transcriptional regulation of related genes (inflammatory factors) due to the loss of IκB inhibition.[@CIT0035] In this study, the expression of P-p65 and P-IκB protein was significantly increased after *MG* infection, while the expression level in baicalin treated group was relatively decreased. This indicated that baicalin could effectively interfere with the activation of NF-κB signaling pathway, reducing the phosphorylation of p65 into the nucleus, and reduce the release of inflammatory factors. In addition, Hong et al (2017) studied molecular docking approach and found that baicalin could bind to IκK and p65-RelA.[@CIT0036] Nevertheless, the exact mechanism of baicalin behind the reduction of p65 phosphorylation is still elusive.

As a receptor for cell recognition of LAMPs, the TLRs act as a response switch during the development of *MG* infection and can regulate subsequent acquired immune responses. The activation of most TLRs induces cellular immune responses, and then produces IL-1β, IL-6, TNF-α, and chemotactic cytokines.[@CIT0037] Our previous results showed that silencing of TLR2 substantially reduced *MG*-triggered autophagy in RAW264.7 cells and markedly reduced *MG*-induced extracellular regulated protein kinase (ERK) in macrophages.[@CIT0017] In the present study, we focused on the role of NF-κB signaling pathway induced by TLR2 involved in *MG*-induced inflammatory responses. Comparing the expression levels of TLR2-NFκB signaling pathway protein in the *MG*G, it can be seen that the TLR2 receptor receives negative regulation of certain cytokines throughout the course of *MG* infection, but the detailed molecular mechanism needs further investigation.

In conclusion, we demonstrated that the anti-inflammatory effects of baicalin (as shown in the schematic diagram ([Figure 7](#F0007){ref-type="fig"}) in a chicken model of *MG*. Baicalin reduced the expression of IL-1β and TNF-α, and alleviated the inflammatory injury caused by *MG* infection. Furthermore, the anti-inflammatory mechanism might be through interfering with the activation of TLR2-NFκB signaling pathway and by inhibiting the phosphorylation of p65 protein both in chicken lungs and DF-1 cells. Our findings may aid in better understanding of the complex mechanisms during host immune responses upon *MG* infection, and baicalin may be an effective drug to treat *MG* infection.Figure 7The schematic diagram showing the therapeutic effects of baicalin against MG infection-mediated inflammation in the lung and DF-1 cells. Green arrows shows enhanced expression, while red arrows shows inhibition.
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